scholarly article | Q13442814 |
P50 | author | Marc Humbert | Q33113039 |
José Labarere | Q40833380 | ||
Martine Reynaud-Gaubert | Q42215588 | ||
Olivier Sitbon | Q57020181 | ||
François Chabot | Q88878234 | ||
Jean-Luc Cracowski | Q89692501 | ||
Ari Chaouat | Q89807931 | ||
Gérald Simonneau | Q98151102 | ||
Carole Schwebel | Q114573953 | ||
Bruno Degano | Q117251152 | ||
Claire Cracowski | Q117251173 | ||
P2093 | author name string | Patrice Faure | |
Azzedine Yaici | |||
P433 | issue | 3 | |
P304 | page(s) | 915-917 | |
P577 | publication date | 2013-11-14 | |
P1433 | published in | European Respiratory Journal | Q12257435 |
P1476 | title | Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension | |
P478 | volume | 43 |
Q36190169 | Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension |
Q47741857 | Beneficial effects of bile acid receptor agonists in pulmonary disease models |
Q42316663 | Chronic hypoxia aggravates monocrotaline-induced pulmonary arterial hypertension: a rodent relevant model to the human severe form of the disease. |
Q60363740 | Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension |
Q58273930 | Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension |
Q33839496 | Endothelial cell global positioning system for pulmonary arterial hypertension: homing in on vascular repair |
Q92257238 | Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension |
Q41922644 | Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension |
Q52899598 | Gut-Lung Connection in Pulmonary Arterial Hypertension. |
Q59309656 | Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition? |
Q33898213 | Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension |
Q55155611 | Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers. |
Q92239221 | Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension |
Q38525952 | Medical Therapies for the Treatment of Pulmonary Arterial Hypertension: How Do We Choose? |
Q27023074 | Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course |
Q48155147 | Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex |
Q90171107 | Protein tyrosine phosphatase L1 represses endothelial-mesenchymal transition by inhibiting IL-1β/NF-κB/Snail signaling |
Q89860088 | Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective |
Q99635470 | Purinergic Dysfunction in Pulmonary Arterial Hypertension |
Q50969268 | Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension. |
Q35165100 | Role of prostacyclin in pulmonary hypertension. |
Q91792991 | SGK1 Mediates Hypoxic Pulmonary Hypertension through Promoting Macrophage Infiltration and Activation |
Q64098812 | Schistosome infection and its effect on pulmonary circulation |
Q89537347 | Systemic Arterial Stiffness in New Diagnosed Idiopathic Pulmonary Arterial Hypertension Patients |
Q58801368 | The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension |
Q45046014 | The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension |
Q92867422 | Vitamin B6 inhibits macrophage activation to prevent lipopolysaccharide-induced acute pneumonia in mice |
Q53767909 | [Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications]. |
Search more.